|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61P 3/10 | |
| A61K 38/20 |
| (11) | Patento numeris | 2683395 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12708029.9 |
| Europos patento paraiškos padavimo data | 2012-03-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-01-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-08-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2012/054174 |
| Data | 2012-03-09 |
| (87) | Numeris | WO 2012/123381 |
| Data | 2012-09-20 |
| (30) | Numeris | Data | Šalis |
| 11305269 | 2011-03-11 | EP | |
| 201161451663 P | 2011-03-11 | US |
| (72) |
KLATZMANN, David, FR
SAADOUN, David, FR
CACOUB, Patrice, FR
ROSENZWAJG, Michčle, FR
PIAGGIO, Eliane, FR
BENSIMON, Gilbert, FR
BERNARD, Claude, FR
|
| (73) |
INSERM (Institut National de la Santé et de la Recherche Médicale),
101, rue de Tolbiac, 75654 Paris Cedex 13,
FR
Assistance Publique - Hōpitaux de Paris, 3 Avenue Victoria, 75004 Paris, FR Sorbonne Université, 21, rue de l`Ecole de Médecine, 75006 Paris, FR |
| (54) | USE OF LOW DOSE IL-2 FOR TREATING TYPE 1 DIABETES |
| USE OF LOW DOSE IL-2 FOR TREATING TYPE 1 DIABETES |